Controlling the Immune Suppressor: Transcription Factors and MicroRnAs Regulating CD73/NT5E

被引:79
作者
Kordass, Theresa [1 ,2 ]
Osen, Wolfram [1 ]
Eichmueller, Stefan B. [1 ]
机构
[1] German Canc Res Ctr, GMP & T Cell Therapy Unit, Heidelberg, Germany
[2] Heidelberg Univ, Fac Biosci, Heidelberg, Germany
关键词
checkpoint molecule; CD73; NT5E; microRNA; transcription factor; T cell; tumor; A2A receptor; HUMAN BREAST-CANCER; ENDOTHELIAL BARRIER FUNCTION; CELL LUNG-CANCER; MELANOMA-CELLS; IN-VIVO; ECTO-5'-NUCLEOTIDASE CD73; IMMUNOSUPPRESSIVE ACTIVITY; PROGNOSTIC BIOMARKER; INTESTINAL EPITHELIA; PROMOTES RESISTANCE;
D O I
10.3389/fimmu.2018.00813
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The NT5E (CD73) molecule represents an ecto-5'-nucleotidase expressed on the cell surface of various cell types. Hydrolyzing extracellular adenosine monophosphate into adenosine and inorganic phosphate, NT5E performs numerous homeostatic functions in healthy organs and tissues. Importantly, NT5E can act as inhibitory immune checkpoint molecule, since free adenosine generated by NT5E inhibits cellular immune responses, thereby promoting immune escape of tumor cells. MicroRNAs (miRNAs) are small non-coding RNA molecules regulating gene expression on posttranscriptional level through binding to mRNAs, resulting in translational repression or degradation of the targeted mRNA molecule. In tumor cells, miRNA expression patterns are often altered which in turn might affect NT5E surface expression and eventually influence the efficacy of antitumor immune responses. This review describes the diverse roles of NT5E, summarizes current knowledge about transcription factors controlling NT5E expression, and highlights the significance of miRNAs involved in the posttranscriptional regulation of NT5E expression.
引用
收藏
页数:8
相关论文
共 92 条
[91]  
Zhou XR, 2007, ONCOL REP, V17, P1341
[92]   CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer [J].
Zhu, Jianjie ;
Zeng, Yuanyuan ;
Li, Wei ;
Qin, Hualong ;
Lei, Zhe ;
Shen, Dan ;
Gu, Dongmei ;
Huang, Jian-an ;
Liu, Zeyi .
MOLECULAR CANCER, 2017, 16